{"url_path":"/sec/srts/8-k/2026-06-02/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 ****Submission","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1494891/0001753926-26-000960-index.html","accession_number":"0001753926-26-000960","cik":"0001494891","ticker":"SRTS","issuer_name":"Sensus Healthcare, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1494891/0001753926-26-000960-index.html","primary_entity_key":"0001494891","primary_entity_name":"Sensus Healthcare, Inc."},"word_count":262,"has_tables":true,"body_markdown":"**Item 5.07****Submission\nof Matters to a Vote of Security Holders**\n\n** **\n\nThe\nAnnual Meeting of Stockholders (the “Annual Meeting”) of Sensus Healthcare, Inc. (the “Company”)\nwas held on May 29, 2026. Proxies for the Annual Meeting were solicited pursuant to Regulation 14A under the Securities Exchange Act\nof 1934, and there was no solicitation in opposition to the Company’s solicitation. The following summarizes all matters voted\non at the Annual Meeting.\n\n \n\n1.\nElection of Directors. Eric Sachetta and Michael J. Sardano were elected as Class II directors for a three-year term to expire\nin 2029. Each nominee was an incumbent director, and no other person was nominated. The tabulation of votes cast was as follows:\n\n \n\n \n \n \n \n**For**\n \n**Against**\n \n**Abstention**\n \n**Broker\nNon-Votes**\n\nEric\nSachetta\n \n \n \n5,532,247\n \n516,567\n \n270,440\n \n5,000,719\n\nMichael\nJ. Sardano\n \n \n \n4,702,852\n \n1,346,063\n \n270,339\n \n5,000,719\n\n \n\n2.\nAdvisory Vote on Executive Compensation. Stockholders approved, on a non-binding advisory basis, the compensation of the Company’s\nnamed executive officers for 2025. The tabulation of votes cast was as follows:\n\n \n\n \n**For**\n \n**Against**\n \n**Abstention**\n \n**Broker\nNon-Votes**\n\n \n4,740,572\n \n856,128\n \n722,554\n \n5,000,719\n\n \n\n3.\nAuditor Appointment Ratification. Stockholders ratified the appointment of Carr, Riggs & Ingram, LLC as the Company’s\nindependent registered public accountant for the fiscal year ended December 31, 2026. The tabulation of votes cast was as follows:\n\n \n\n \n**For**\n \n**Against**\n \n**Abstention**\n\n \n10,738,792\n \n148,466\n \n432,715\n\n** **\n\n \n\n  \n\n \n\n \n\nSIGNATURES\n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n**SENSUS HEALTHCARE, INC.**\n\n \n \n \n\n \n \n \n\nDate: June 2, 2026\nBy:\n/s/ Javier Rampolla\n\n \n \nJavier Rampolla\n\n \n \nChief Financial Officer"}